Chronic Donepezil Treatment Is Associated with Slowed Cognitive Decline in Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|12|4|295-300

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.12, Iss.4, 2001-05, pp. : 295-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is Antidepressant Treatment Associated with Reduced Cognitive Decline in Alzheimer’s Disease?

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 4, 2008-03 ,pp. : 372-379

Karger

Access to resources Recommend Favorite

Plasma Levels of Antioxidants Are Not Associated with Alzheimer’s Disease or Cognitive Decline

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 2-3, 2005-02 ,pp. : 134-139

Karger

Access to resources Recommend Favorite

Hallucinations, Cognitive Decline, and Death in Alzheimer’s Disease

By  

Neuroepidemiology, Vol. 26, Iss. 2, 2006-02 ,pp. : 68-75

Karger

Access to resources Recommend Favorite

SPECT-Identified Neuroanatomical Predictor of the Cognitive Effects of Donepezil Treatment in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 26, Iss. 6, 2008-12 ,pp. : 556-566

Karger

Access to resources Recommend Favorite

Economic Evaluation of Donepezil Treatment for Alzheimer’s Disease in Japan

By  

Dementia and Geriatric Cognitive Disorders, Vol. 13, Iss. 1, 2001-12 ,pp. : 33-39

Karger

Access to resources Recommend Favorite